A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

NCT07641517 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Chronic Pain

Interventions

DRUG: LY4065967
DRUG: Placebo

Sponsor

Eli Lilly and Company